Stock comparison
ELI LILLY & Co is 140.5x more valuable than TG THERAPEUTICS, INC. by market capitalization ($1.282 T vs $9.12 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 140.5x more valuable than TG THERAPEUTICS, INC. by market capitalization ($1.282 T vs $9.12 B).
Market value leader
LLY
ELI LILLY & Co is 140.5x more valuable than TG THERAPEUTICS, INC. by market capitalization ($1.282 T vs $9.12 B).
Revenue leader
LLY
TGTX: $616.29M vs LLY: $65.18B.
Profit leader
LLY
TGTX: $447.20M vs LLY: $20.64B.
Margin leader
TGTX
TGTX: 72.6% vs LLY: 31.7% net margin.
| Metric | TGTX | LLY |
|---|---|---|
| Market cap | $9.12 B | $1.282 T |
| US-listed rank | #974 | #10 |
| Revenue (latest FY) | $616.29M | $65.18B |
| Net income (latest FY) | $447.20M | $20.64B |
| Net margin | 72.6% | 31.7% |
| P/E (trailing FY) | 20.4x | 62.1x |
| SEC filings | 1,133 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 140.5x more valuable than TG THERAPEUTICS, INC. by market capitalization ($1.282 T vs $9.12 B).
In their latest fiscal years, TG THERAPEUTICS, INC. reported $616.29M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: TG THERAPEUTICS, INC. and ELI LILLY & Co, or browse the full rankings.